Protein structures predicted using artificial intelligence will aid medical research, but the greatest benefit will come if clinical data can be similarly used to better understand human disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Improving drug effectiveness using a second-generation artificial intelligence system based on the constrained-disorder principle to incorporate variability into drug design and administration: a perspective
Discover Applied Sciences Open Access 10 February 2026
-
AI-driven virtual screening platform identifies novel NSUN2 inhibitor candidates for targeted cancer therapy: a computational drug discovery approach
npj Precision Oncology Open Access 30 January 2026
-
Neuropsychopharmacology in the era of artificial intelligence and biomolecule prediction software
NPP—Digital Psychiatry and Neuroscience Open Access 30 June 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout



References
CASP14—14th Community Wide Experiment on the Critical Assessment of Techniques for Protein Structure Prediction. Retrieved from https://predictioncenter.org/casp14/ (accessed 27 September 2021).
Jumper, J. et al. Nature 596, 583–589 (2021).
Tunyasuvunakool, K et al. Nature 595, 590–596 (2021).
Jones, D. T. & Thornton, J. M. Crystallogr. News 156, 6–9 (2021).
AlQuraishi, M. Curr. Opin. Chem. Biol. 65, 1–8 (2021).
Diwan, G. D. et al. J. Mol. Biol. 167180 (2021).
Workman, P. The Institute of Cancer Research blogs 2021. Retrieved from https://www.icr.ac.uk/blogs/the-drug-discoverer/page-details/reflecting-on-deepmind-s-alphafold-artificial-intelligence-success-what-s-the-real-significance-for-protein-folding-research-and-drug-discovery
wwPDB Consortium. Nucleic Acids Res. 47, D520–D528 (2019).
Hopkins, A. L. & Groom, C. R. Nat. Rev. Drug. Discov. 1, 727–730 (2002).
Waterhouse, A. et al. Nucleic Acids Res. 46, W296–W303 (2018).
UniProt Consortium. Nucleic Acids Res. 49, D480–D489 (2021).
Laskowski, R. A., Jablonska, J., Pravda, L., Varekova, R. S. & Thornton, J. M. Protein Sci. 27, 129–134 (2018).
Mirdita, M., Ovchinnikov, S. & Steinegger, M. Preprint at https://doi.org/10.1101/2021.08.15.456425 (2021).
Baek, M. et al. Science 373, 871–876 (2021).
Batool, M., Ahmad, B. & Choi, S. Int. J. Mol. Sci. 20, 2783 (2019). (11).
Stefl, S. et al. J. Mol. Biol. 425, 3919–3936 (2013).
Landrum, M. J. et al. Nucleic Acids Res. 48, D835–D844 (2020).
COVID-19 protein structures in the PDB. Retrieved from https://www.ebi.ac.uk/thornton-srv/databases/pdbsum/covid-19.html (accessed 3 September 2021).
Lewin, H. A. et al. Proc. Natl Acad. Sci. USA 115, 4325–4333 (2018).
Darwin Tree of Life. Retrieved from https://www.darwintreeoflife.org (accessed 27 September 2021).
Author information
Authors and Affiliations
Contributions
J.M.T. wrote the first draft of the article, and R.A.L. and N.B. edited and improved it. R.A.L. performed the analyses and created the figures.
Corresponding author
Ethics declarations
Competing interests
J.M.T. sits on the board of Health Data Research UK.
Rights and permissions
About this article
Cite this article
Thornton, J.M., Laskowski, R.A. & Borkakoti, N. AlphaFold heralds a data-driven revolution in biology and medicine. Nat Med 27, 1666–1669 (2021). https://doi.org/10.1038/s41591-021-01533-0
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41591-021-01533-0
This article is cited by
-
AI-driven virtual screening platform identifies novel NSUN2 inhibitor candidates for targeted cancer therapy: a computational drug discovery approach
npj Precision Oncology (2026)
-
Improving drug effectiveness using a second-generation artificial intelligence system based on the constrained-disorder principle to incorporate variability into drug design and administration: a perspective
Discover Applied Sciences (2026)
-
Generative artificial intelligence in medicine
Nature Medicine (2025)
-
Neuropsychopharmacology in the era of artificial intelligence and biomolecule prediction software
NPP—Digital Psychiatry and Neuroscience (2025)
-
PIPENN-EMB ensemble net and protein embeddings generalise protein interface prediction beyond homology
Scientific Reports (2025)